Corporate Travel Management

About the author:

Belinda Moore
Author name:
By Belinda Moore
Job title:
Senior Analyst
Date posted:
21 December 2015, 12:12 PM
Sectors Covered:
Agriculture, Food & Beverage, Travel and Chemicals

Key points

  • Corporate Travel Management (CTD) has announced its sixth acquisition in the US with Montrose Travel. The acquisition provides CTD with the scale to leverage its buying power.
  • CTD has also upgraded its FY16 EBITDA guidance (expected to grow by an impressive 38.5% in FY16).

Gaining scale and rounding out the US

Montrose Travel is a family owned travel management company in California, one of the higher value corporate travel markets in the US. The business has a long and successful history, and has six operating divisions - Loyalty Rewards, Vacation Travel, Romantic Travel, Business Travel, Group Travel and Independent Contractors. 

Following this acquisition, CTD's business will span over 19 cities in the US and it will be one of the top 12 players in the US corporate travel market. On an annualised basis, CTD's combined North American Total Transaction Value (TTV) will be greater than US$750m or A$1bn. Notably, Montrose Travel has a great loyalty rewards program which CTD hopes to expand across the US and globally to enhance its value proposition to clients.

Highly EPS accretive

Base consideration for Montrose Travel is approximately US$34.3m or A$47.6m, which represents an attractive 6x EBITDA. Consideration is a mixture of cash, USD nominated debt and CTD scrip to the founders (20%). To incentivise Montrose Travel to beat its targets, there is an additional earn-out. 

The transaction will be completed on 1 January 2016 and is forecast to be earnings accretive in FY16. Based on our modelling the acquisition is:

  • 5.4% EPS accretive in FY16;
  • 8.0% EPS accretive in FY17; and
  • 8.1% EPS accretive in FY18.

We expect CTD to make further acquisitions in the US during the 2H16.

Investment view

A sizeable acquisition and earnings upgrade were the catalysts required to re-rate the stock, and we view the Montrose Travel acquisition positively. We expect that the next update from CTD will be a strong 1H16 result in February. We retain our Add recommendation and upgrade our share price target.

More information

Morgans clients can login to access the full research report and our share price target for Corporate Travel Management (CTD). If you are interested in becoming a client, please contact your nearest Morgans office.

Disclaimer(s): Analyst owns shares.

The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents ("Morgans") do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

  • Print this page
  • Copy Link